| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |